Results 211 to 220 of about 1,493,771 (318)
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Commentary on Nieto et al.: The heterogeneity of drug craving and considerations as a treatment endpoint. [PDF]
Strickland JC, Bergeria CL, Acuff SF.
europepmc +1 more source
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
Comment les processus de civilisation se sont-ils prolongés? De la seconde nature à la troisième nature [PDF]
Afd ASW +2 more
core
Developing Digital Self-Regulation in Adolescence: A Developmental Self-Determination Model of Digital Self-Regulation. [PDF]
Wang MT.
europepmc +1 more source
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi +11 more
wiley +1 more source
Measuring readiness for disaster response in physiotherapy education: development and validation predisposition assessment tool. [PDF]
Rosado MDL, Silva C, de Sá CDSC.
europepmc +1 more source

